Additional files for BuruliRifDACC

SPIRIT checklist for Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose Rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana This project is funded by the National Institute for Health and Care Research (NIHR) under its Research and Innovation for Global Health Transformation (RIGHT) Programme [Grant Reference Number NIHR200125]. The views expressed are those of the author(s) and not necessarily those of the NIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.